Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05341557
What this trial is testing

BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Who this might be right for
Advanced Solid TumorLymphomaNSCLC+1 more
Betta Pharmaceuticals Co., Ltd. 110
Early research (Phase 1)UnknownNCT04213612
What this trial is testing

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Who this might be right for
Unrecognized Condition
Sun Yat-sen University 21
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT04308330
What this trial is testing

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Who this might be right for
Ewing SarcomaRhabdomyosarcomaWilms Tumor+3 more
New York Medical College 30
Testing effectiveness (Phase 2)Study completedNCT01294670
What this trial is testing

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Who this might be right for
Solid TumorsRelapsed/Refractory Sarcomas
Memorial Sloan Kettering Cancer Center 27
Early research (Phase 1)UnknownNCT02897986
What this trial is testing

Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

Who this might be right for
Pediatric Cancer
Assistance Publique Hopitaux De Marseille 54
Early research (Phase 1)Study completedNCT01453283
What this trial is testing

Tabectedin to Treat Children and Adolescents With Cancer

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT04836195
What this trial is testing

Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Who this might be right for
B-cell Non Hodgkin LymphomaAdvanced Solid Tumor
Pacylex Pharmaceuticals 29
Early research (Phase 1)Ended earlyNCT02890368
What this trial is testing

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Who this might be right for
Solid TumorsMycosis FungoidesMelanoma+5 more
Pfizer 56
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Early research (Phase 1)Not Yet RecruitingNCT07779798
What this trial is testing

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

Who this might be right for
Advanced Solid TumorsRecurrent or Progressive GlioblastomaRelapse or Refractory Myeloid Malignancies
Crossbow Therapeutics, Inc. 120
Early research (Phase 1)Study completedNCT05309187
What this trial is testing

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Who this might be right for
Solid Tumor, Adult
Immune-Onc Therapeutics 22
Early research (Phase 1)Study completedNCT03406949
What this trial is testing

MGD009/MGA012 Combination in Relapsed/Refractory Cancer

Who this might be right for
Advanced Solid Tumors
MacroGenics 25
Testing effectiveness (Phase 2)Study completedNCT03455140
What this trial is testing

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

Who this might be right for
CancerPediatric Solid TumorPediatric AML+1 more
University of Birmingham 49
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Early research (Phase 1)Not Yet RecruitingNCT07773454
What this trial is testing

Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
CancerPediatric Cancer
Exelixis 18
Next Page